Recent headlines

September 06, 2022

Moving forward after launching the contract with GMA for it’s nationwide advertising, a huge leap for the company, Ifrenel has successfully obtained its Certificate of Product Notification (CPN) for two of its first products: Ifrenel and Clayn. Read More>>>

July 15, 2022

With the development of Ifrenel Technology in the United States, Ifrenel, Inc. has ventured in the Philippine skin care market through online platforms as it opened its doors in the midst of the pandemic last 2021.   The first year was spent applying for FDA license to operate while solving logistics and developing our online platform.  Ifrenel has been active on Instagram and Facebook to create a robust online presence in social media. Read More>>>

June 20, 2022

Research and development are integral parts of the long term plan of Ifrenel, Inc. to develop advanced yet simple technologies in skin care. The cosmetic and skin care industry are dominated by expensive and “me too” products that in the end performs poorly for the consumer’s benefit. Today, the company announces completion of formulation and efficacy testing of our new Clayn daily moisturizer and Clayn Night scrub. Read More>>>

June 20, 2022

The FDA granted Ifrenel, Inc.’s the license to operate on December 24, 2021. Because of the Covid pandemic, granting of licenses took many months because FDA offices are on work from home basis for most of its staff. This was a much awaited and welcome news in time for the holiday season. Read More>>>

September 1, 2020

As the company expands its operations, we have moved from our initial start-up offices in larger facility within the Poblacion area of Miag-ao. Currently, the company occupies the 2nd and 3rd floor of the Nochete Building. The 3rd floor area has been set aside as a training area for marketing activities and meetings, surrounded by a covered rooftop flower garden and a view of the mountains. Read More>>>